| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
6,051,400 |
|
|
Total
Indirect Shares :
|
17,974,130 |
| |
%
Held by Insiders:
|
22.25% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Rajavelu Esther |
|
2026-02-02 |
1,100,008 |
2023-11-13 |
0 |
| Mahadevia Ankit |
|
2025-08-28 |
703,294 |
2018-07-05 |
0 |
| Keutzer Timothy |
|
2025-08-28 |
739,744 |
|
0 |
| Jackson Scott Thomas |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Deshpande Milind |
|
2025-06-12 |
91,454 |
2022-09-15 |
0 |
| Thomas Frank E |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Tregoning Kathleen |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Pottage John C Jr |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Vink Patrick V.j.j. |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Smith Cynthia |
|
2025-06-12 |
75,000 |
2022-09-15 |
0 |
| Shukla Sath |
|
2025-02-05 |
1,736,883 |
2021-08-26 |
0 |
| Hamed Kamal |
|
2024-02-02 |
788,117 |
2022-09-12 |
0 |
| Joseph Tamara L |
|
2024-02-02 |
531,615 |
2021-08-26 |
0 |
| Larkin Cristina |
Chief Operating Officer |
2022-02-01 |
63,581 |
2017-11-06 |
0 |
| Melnick David A. |
Chief Medical Officer |
2022-02-01 |
62,081 |
|
0 |
| Sendek Joel |
Chief Financial Officer |
2018-07-05 |
15,181 |
2017-11-06 |
10,181 |
| Glaxosmithkline Plc |
10% Owner |
2017-11-06 |
0 |
2022-11-07 |
9,190,606 |
| Breum Casper |
Director |
2017-11-06 |
0 |
2017-11-06 |
1,091,774 |
| Goyal Vikas |
Director |
2017-11-06 |
0 |
2017-11-06 |
1,854,006 |
| Formela Jean Francois |
Director |
2017-11-06 |
0 |
2017-11-06 |
2,408,128 |
| Aquilo Capital, L.p. |
10% Owner |
|
0 |
2022-09-22 |
3,419,435 |
| Parr Thomas R Jr |
|
|
0 |
|
0 |
|
0.15 (7.01%) 
